June 2025

What drives persistent symptoms after COVID-19? A newly published study from the EuCARE team explores how SARS-CoV-2 RNAemia (the presence of viral RNA in the blood) and immune dysregulation may explain the early persistence of symptoms in unvaccinated, hospitalised patients. 📌 Key findings:– Patients with persistent symptoms had a weaker immune response and lower levels of […]

This systematic review and meta-analysis examined how pandemic-related healthcare disruptions led to delays in melanoma diagnoses, resulting in a shift toward more advanced and severe cases. Key findings: ✅ A higher prevalence of poor prognostic factors (thickness, ulceration, mitosis). ✅ A significant increase in advanced-stage melanoma (Stage III & IV). ✅ Highlights the urgent need for updated pandemic preparedness plans to safeguard oncological care. Read

This week, the EuCARE team participated in the 23rd European Meeting on HIV & Hepatitis, held in the vibrant city of Barcelona 🇪🇸 We proudly contributed with:🎤 1 oral presentation📌 2 poster presentations This was a fantastic opportunity to share our work, especially on the SCHOOL studies and clinical cohorts, while engaging in meaningful exchanges